Phospholipid transfer protein (PLTP), one of the key lipid transfer proteins in plasma and cerebrospinal fluid, is nearly ubiquitously expressed in cells and tissues. Functions of secreted PLTP have been extensively studied. However, very little is known about potential intracellular PLTP functions. In the current study, we provide evidence for PLTP localization in the nucleus of cells that constitutively express PLTP (human neuroblastoma cells, SK-N-SH; and human cortical neurons, HCN2) and in cells transfected with human PLTP (Chinese hamster ovary and baby hamster kidney cells). Furthermore, we have shown that incubation of these cells with leptomycin B (LMB), a specific inhibitor of nuclear export mediated by chromosome region maintenance 1 (CRM1), leads to intranuclear accumulation of PLTP, suggesting that PLTP nuclear export is CRM1-dependent. We also provide evidence for entry of secreted PLTP into the cell and its translocation to the nucleus, and show that intranuclear PLTP is active in phospholipid transfer. These findings suggest that PLTP is involved in novel intracellular functions.
Introduction
Phospholipid transfer protein (PLTP) is a versatile transfer protein with predicted protein molecular mass of approximately 55 kDa with signal peptide, or 53 kDa without [1] . Posttranslational modifications, such as N-glycosylation, account for the difference between the predicted molecular mass, 53 kDa, and observed mass of 81 kDa of the secreted protein [1] . Secreted PLTP is bound to lipoprotein particles, and associates with apolipoprotein A-I (apoA-I) and E (apoE), and with lipoproteins containing other apolipoproteins [2, 3] . PLTP functions have been associated with the metabolism of lipoproteins, particularly high-density lipoproteins (HDL) (reviewed in [4] ). PLTP has been shown to modulate phospholipid and cholesterol transfer between lipoproteins, as well as between lipoproteins and cells [5] [6] [7] . PLTP also transfers apolipoprotein E (apoE), α-tocopherol and other molecules such as cerebrosides and diacylglycerides [7] [8] [9] [10] [11] .
PLTP is expressed by nearly all types of cells and tissues, with wide variation in expression patterns ( [5, 12] and unpublished data). For example, neighboring neurons in Cornu Amonis (CA) layers 1 and 2 in human hippocampus differ significantly in PLTP expression [12] . Interestingly, neurons in the CA1 layer, which express significantly lower levels of PLTP than other hippocampal neurons, are particularly sensitive to oxidative stress [12, 13] , and PLTP is one of the key molecules for maintenance of the brain anti-oxidative properties through regulation of tissue levels of α-tocopherol [11] . These findings, along with nearly ubiquitous, yet differential expression of PLTP in other cells and tissues suggest that PLTP has physiological roles other than purely extracellular functions related to lipoprotein metabolism. Although the role of PLTP as a secretory protein has been extensively studied, nothing is known about the possible intracellular functions of this protein.
In our immunohistochemical studies of the human brain [12] , we noticed intranuclear staining in neuronal cells using several different antibodies against PLTP (unpublished data). We tested these initial observations in order to establish whether PLTP is indeed present in the nucleus. In this study we provide evidence for PLTP presence and activity in the nuclear compartment and discuss motifs that could be involved in PLTP nuclear import and export, implying that PLTP has novel intracellular functions beyond that of extracellular lipid transport.
Materials and methods

Materials
Dulbecco modified cell culture media (DMEM) were purchased from Lonza (Walkersville, MD). Chinese hamster ovary cells prepared for Flp-In vectors, Flp-In vectors and specialized growth media were purchased from Invitrogen (Carlsbad, CA). Fetal calf serum was obtained from HyClone (Logan, UT). Mutagenesis kits were purchased from Qiagen (Valencia, CA). Leptomycin B (LMB), bovine skin collagen, Triton X-100 and antibodies against lamin A were purchased from Sigma-Aldrich (St. Louis, MO). Nunc Lab-Tech chamber slides and other cell culture plastic-ware were purchased from VWR (West Chester, PA). Methanol-free formaldehyde (16%) was purchased from Polysciences (Warrington, PA). Monoclonal antibody against PLTP was produced at the Northwest Lipid Research Laboratory, in collaboration with Dr. Marcovina [12] . Secondary antibodies for Western blotting were purchased from eBioscience (San Diego, CA). Antibodies against TATA binding protein (TBP) for Western loading control were purchased from Abcam (Cambridge, MA). Biotinylated secondary antibodies (horse anti-mouse), Vectastain ELITE ABC, NovaRED and DAB kits, horse serum, hematoxylin, AquaMount and VectaShield mounting media were purchased from Vector Laboratories (Burlingame, CA). Fluorescently labeled secondary antibodies, chicken anti-mouse AlexaFluor 488 and goat anti-rabbit AlexaFluor 594 antibodies, and Image-iT FX signal enhancer were from Molecular Probes/Invitrogen (Eugene, OR). PLTP tagged with enhanced green fluorescent protein (PLTP-EGFP) and mock vectors were a kind gift from Dr. Vesa Olkkonen, National Public Health Institute, Helsinki, Finland [14] . Cytoplasmic and nuclear proteins were isolated using NE-PER kit with addition of protease inhibitor cocktail, Halt (Pierce, Rockford, IL).
Cell culture
Experiments were conducted in human neuroblastoma cells (SK-N-SH), human cortical neurons (HCN2; ATCC CRL-10743), Chinese hamster ovary (CHO) and baby hamster kidney (BHK) cells. Cells were incubated in 5% CO 2 , at 37°C, supplemented with 5% (SK-N-SH), 10% (CHO and BHK) or 15% (HCN2) serum in growth media. For standard immunocytochemistry and fluorescent live-cell imaging cells were plated in 8-chamber slides, while cells prepared for confocal microscopy were grown on collagen-treated coverslips in six-well plates. Cells were incubated without or with 10 ng/ml of LMB for up to 24 h. All experiments were performed in serum-free media, thus eliminating potential external source of PLTP, conducted in triplicate, and replicated multiple times.
PLTP mutagenesis
Site-directed mutagenesis was conducted using wild-type (WT) PLTP cDNA [1] as a template, using QuickChange site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. Site-directed in vitro mutagenesis was accomplished by hybridizing a plasmid containing the PLTP insert (human PLTP C-his tag/pcDNA5/FRT) to oligonucleotides which are complementary to the target template except for a region of mismatch near the center, containing the desired serine-to-alanine mutations. We mutated the following residues in PLTP: S49A, S79A, S102A, and S128A within the putative N-glycosylation motifs (N/X/S-T; numbering based on mature protein without signal peptide). All created cDNA were verified by digestion and sequencing prior to transfection.
PLTP expression
Recombinant PLTP (rPLTP) constructs containing His tag were transfected into CHO Flp-In-Ready cells (Invitrogen) using Lipofectamine 2000, and clones were selected using Hygromycin B (0.6 mg/ml; Invitrogen). PLTP-EGFP constructs were transfected into BHK cells using Lipofectamine 2000, and positive clones were selected using G418 (1 mg/ml; Invitrogen). Highest expressing clones for PLTP-EGFP were selected by measurement of fluorescence (excitation/emission 488/535 nm), and all PLTP clones (wild-type His-tagged and PLTP-EGFP, as well as mutant PLTP) were confirmed by Western blot analysis using PLTP-specific monoclonal antibodies, and by measurement of PLTP phospholipid transfer activity in an in vitro assay [15] .
Immunocytochemistry
Following incubation, cells prepared for standard, chromogenic ICC were fixed with 95% ethanol for 10 min, washed and incubated for 30 min with 3% hydrogen peroxide to reduce endogenous peroxidase. Slides were blocked with horse serum for 20 min, and incubated with mouse anti-PLTP antibody (20 μg/ml) overnight at 4°C, followed by biotinylated horse anti-mouse antibody (5 μg/ml) for 30 min. The signal was amplified using Vectastain ELITE ABC reagents for 30 min, and stained using DAB or NovaRED kits. The slides were counterstained with hematoxylin, coverslipped and observed under Olympus microscope. Digital images were created using Nikon E990 digital camera. Cells prepared for confocal microscopy were grown on coverslips, incubated without or with 10 ng/ml LMB for up to 24 h, fixed using 3.7% formaldehyde for 15 min, and incubated with primary antibodies against PLTP (mouse; 20 μg/ml) and Lamin A (rabbit; 2.5 μg/ ml), as a nuclear marker, at 4°C overnight. Alexa Fluor secondary antibodies (chicken anti-mouse Alexa Fluor 488, 5 μg/ml; and goat anti-rabbit Alexa Fluor 594, 3 μg/ml) for 45 min, rinsed with PBS and mounted using VectaShield HardSet mounting medium. The slides were observed under confocal Zeiss LSM 510 Meta microscope, using water-immersion objective, and recorded using Zeiss LSM 510 software, version 4.1 SP1.
Live cell imaging
Live cells transfected with PLTP-EGFP and grown in 8-chamber slides in phenol red-free media, incubated without or with LMB (10 ng/ml), were observed under Zeiss Axiovert inverted fluorescent microscope, using QColor 3 digital camera and QCapture Pro software.
PLTP re-entry experiment
Phenol red-free media from control BHK cells and cells transfected with PLTP-EGFP were collected after a 24-hour incubation, centrifuged to remove cells, concentrated using 30 kDa cut-off Amicon Ultra-4 centrifugal filter device, and added to control BHK cells incubated with vehicle (70% methanol) or 10 ng/ml LMB for 24 h. Following Fig. 1 . PLTP is present in nuclear protein extracts of SK-N-SH neuroblastoma and human cortical neurons, HCN2 cells, and its nuclear export is chromosome region maintenance 1 (CRM1) dependent. (A) Isolated SK-N-SH nuclear proteins from three different samples were resolved using SDS-PAGE, and visualized using Western blot analysis with monoclonal anti-PLTP antibody. (B) PLTP Western blot analysis of nuclear proteins isolated from HCN2 cells incubated without (−) or with (+) 10 ng/ml LMB, a specific inhibitor of nuclear export mediated by CRM1, for 24 h under serum-free conditions. PLTP was identified using monoclonal anti-PLTP antibody. Loading control was evaluated using anti-TATA binding protein (TBP). Secondary antibody controls were negative (not shown).
incubation, cells were fixed with formaldehyde and observed under confocal microscope.
Western blot
Plated cells were incubated in the presence or absence of LMB from 1 to 24 h. Following incubation, cells were washed, scraped and cytoplasmic and nuclear extract proteins were isolated using NE-PER kit (Pierce) following the manufacturer's instructions. Briefly, cells were lysed using CERI buffer containing protease inhibitor cocktail (Halt protease inhibitor cocktail, Pierce). Following cell lysis, CERII buffer was added, and cells were incubated, vortexed and centrifuged at 16,000 ×g at 4°C. Cytoplasmic extract was separated and stored at −80°C until use. Nuclear pellet was resuspended in NER buffer containing protease inhibitor cocktail. Lysed nuclei were subjected to centrifugation, and supernatant containing nuclear extract was stored at −80°C until use. Equal amounts of nuclear proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on 4-12% Criterion gel (Bio-Rad, Hercules, CA), transferred to nitrocellulose membrane using semi-dry transfer system (BioRad), and subjected to Western blot analysis using monoclonal anti-PLTP antibody (1 μg/ml, overnight incubation at 4°C), and anti-mouse secondary antibody that reacts exclusively with non-denatured immunoglobulin, thus eliminating false positive results (TrueBlot, eBioscience, San Diego, CA; 0.2 μg/ml, 2 h incubation at room temperature). Loading control was assessed using anti-TBP (Abcam; 0.08 μg/ml). Positive bands were visualized using West Femto SuperSignal kit (Pierce). Membranes were digitally scanned using Kodak CF400 Gel Imager.
Phospholipid transfer activity assay
PLTP-mediated phospholipid transfer activity was assessed using PLTP phospholipid transfer activity assay [15] . Nuclear proteins were assayed for the ability to transfer C14-labeled phospholipid from donor liposome particles to the acceptor particles (plasma HDL without measurable PLTP activity). All values were adjusted for the background transfer, and PLTP activity was calculated as percent of phospholipid transfer per nanogram of total nuclear protein per hour (%/ng/h). PLTP-mediated phospholipid transfer activity was confirmed using anti-PLTP antibody inhibition. Nuclear extracts were incubated 1 and 2) , or with leptomycin B (LMB; lanes 3 and 4) . PLTP was identified using monoclonal anti-PLTP antibody. Loading control was evaluated using anti-TATA binding protein (TBP). Secondary antibody controls were negative (not shown).
overnight at 4°C with 1 μg of chicken anti-PLTP antibody [16] , using the minimal concentration that elicited complete inhibition of PLTP activity in the control plasma sample. Samples were then centrifuged for 20 min at low speed at 4°C. The supernatant was evaluated for phospholipid transfer activity. Control chicken IgG was used as negative control, and assay performance was evaluated using a plasma sample with known PLTP activity inhibition under identical conditions.
Computer analyses
Putative nuclear export motifs in the PLTP sequence were evaluated using online Nuclear Export Server (NetNES 1.1; http:// www.cbs.dtu.dk/services/NetNES/), and nuclear import motifs were assessed using an online tool (http://cubic.bioc.columbia.edu/cgi/var/ nair/resonline.pl). Following these analyses, PLTP protein sequence was further evaluated for nuclear export and nuclear import sequences based on the published consensus sequences [17] [18] [19] [20] [21] .
Statistical analyses
Statistical analyses were performed using Statistica for Windows, StatSoft, Inc., 2000 (Tulsa, OK). P-values b 0.05 were considered statistically significant.
Results
To establish whether or not PLTP is present in the nuclei of neurons, we isolated nuclear proteins from SK-N-SH neuroblastoma cells, and analyzed them by Western blot. The analysis suggested that PLTP is indeed present in the nuclei (Fig. 1A) . Similar results were obtained using a nuclear extract isolated from human cortical neurons (HCN2; Fig. 1B) .
To evaluate whether PLTP accumulates in nuclei due to inhibition of the chromosome region maintenance 1 (CRM1) protein, the main nuclear export protein, we incubated neuronal cells with leptomycin B (LMB), a specific inhibitor of CRM1 [22] [23] [24] . HCN2 cells were incubated with LMB, and isolated nuclear proteins were evaluated by Western blot analyses (Fig. 1B) . Similar results were obtained using neuroblastoma (SK-N-SH) cells (not shown). Additionally, we evaluated how glycosylation affects nuclear accumulation of PLTP. Removal of carbohydrate from four N-glycosylation sites of PLTP, using sitedirected mutagenesis, increased the amount of PLTP in the nuclei of transfected CHO cells, and its retention in the presence of LMB (Fig. 2) .
We also performed immunocytochemistry on cells incubated with or without LMB, using monoclonal antibody against PLTP. Our analyses confirmed that incubation of SK-N-SH and HCN2 cells with LMB leads to accumulation of PLTP in the nuclei (Figs. 3 and 4) . To confirm that accumulated protein is indeed PLTP, we incubated mock-transfected and PLTP-EGFP transfected BHK cells with LMB. One hour after the addition of LMB, we observed live cells under the fluorescent microscope to evaluate localization of PLTP-EGFP (Fig. 5a ). At the end of the experiment, fixed cells transfected with PLTP-EGFP were also observed under confocal microscope to confirm intranuclear localization of PLTP-EGFP (Fig. 5b-h ). Both fluorescent and confocal microscopy confirmed that PLTP is present in the nuclei of the transfected cells, and that it accumulates in nuclei of cells incubated with LMB.
In order to establish whether secreted PLTP can enter the cell and nucleus, conditioned media from control BHK cells and media of BHK cells transfected with PLTP-EGFP were incubated with the control BHK cells for 24 h in the presence or absence of LMB, and observed under To establish whether nuclear PLTP is active in phospholipid transfer, we performed an in vitro phospholipid transfer assay using nuclear extract from HCN2 cells. Intranuclear PLTP was active in phospholipid transfer and PLTP-mediated phospholipid transfer activity was significantly increased in cells incubated with LMB (control 0.36 ± 0.05% transfer/ng nuclear protein/h vs. LMB 1.72 ± 0.43%/ng/h). Incubation with specific chicken polyclonal anti-PLTP antibody significantly reduced measured intranuclear phospholipid transfer activity (control with anti-PLTP antibody 0.11 ± 0.05%/ng/h, and LMB with anti-PLTP antibody 0.16 ± 0.06%/ng/h; Fig. 7) .
We also conducted computer analysis of the PLTP protein sequence for the presence of known nuclear motifs involved in nuclear import and export. The classical nuclear localization signal (NLS) contains basic amino-acids (R = arginine, K = lysine, and H = histidine) in a monopartite sequence [K(K/R)XK(K/R)], which typically requires the presence of lysine residue at the first position, or in a bipartite sequence that consists of two groups of basic amino-acids separated by 10-12 amino-acid linker region [17] [18] [19] [20] . Using an online tool for search of the consensus nuclear localization sequences (see Materials and methods), we could not establish that PLTP contains a consensus sequence for nuclear import, either the canonical or the bi-partite sequence. This finding is not unusual, as nuclear import sequences are more heterogeneous, although most of them require presence of a cluster of basic amino-acids. Two regions fulfilling this later requirement were identified in PLTP, one in the carboxyl-terminal and one in the amino-terminal barrel of PLTP (Table 1 ). In addition, a newly identified NLS motif (S/T-P-S/T), which responds to extracellular stimuli and requires phosphorylation for transfer into the nucleus [25] , is present at the C-terminal of PLTP (Table 1) .
Furthermore, we identified several potential consensus nuclear export sequence (NES) motifs (consensus sequence: ΦX(2-3)ΦX(2-3)ΦXΦ where Φ stands for either leucine, L, isoleucine, I, valine, V, phenylalanine, F, or methionine, M; while X stands for any aminoacid) [21] . Putative consensus NES sequences are distributed in both the amino-and carboxyl-terminal portion of the PLTP molecule . Intranuclear PLTP-mediated phospholipid transfer activity in HCN2 cells. Nuclear extracts of HCN2 cells incubated without (control) or with LMB (10 ng/ml) for 24 h were analyzed for PLTP-mediated phospholipid transfer activity before and after incubation with chicken polyclonal anti PLTP antibody. Transfer of radioactively-labeled (C14) phospholipid from liposome to HDL particles was measured in vitro. Activity in phospholipid transfer is expressed as percent radioactively labeled phospholipid transferred to the acceptor per nanogram of total nuclear protein per hour (%/ng/h). (Table 1) . Further evaluation by the online tool, NetNES 1.1, suggested that each of the identified putative NES motifs fulfills the basic requirements for nuclear export. Functionality of these motifs remains to be established.
Discussion
In the current study, we present evidence for PLTP localization in the nucleus of neuronal cells, as well as in mammalian ovary and kidney cells transfected with human PLTP. These findings indicate that PLTP is present in the nuclei of different cell types, and its export from the nucleus is CRM1-dependent. We also provide evidence for reentry of extracellular PLTP into the cell and translocation into the nucleus. Furthermore, the assay of PLTP phospholipid transfer activity before and after incubation with anti-PLTP antibody confirmed that intranuclear PLTP is active in phospholipid transfer.
The current paradigm for protein localization implies that proteins destined for secretion are targeted to the endoplasmic reticulum (ER) by a signal peptide sequence at the beginning of mRNA transcription, then transferred to Golgi and secreted into extracellular space. It is, therefore, unclear by which mechanism PLTP enters the nucleus. One possibility is that the signal peptide coded by Exon 2 in PLTP may be omitted through alternative splicing, or masked by some other mechanism. An alternative explanation would be that secreted PLTP re-enters the cells, escapes the endocytic pathway and enters the nucleus. This type of nuclear translocation is rare, but has been reported. For example, apoE, a molecular partner of PLTP, has been shown to translocate into the nucleus following entry into cells through an apoE receptor-dependent mechanism [26] . Furthermore, apolipoprotein D has been shown to translocate into the nucleus [27] . One potential explanation may be in the fact that PLTP, apoE and apoD are bound to lipoprotein particles, which could be taken up by the cells as holoparticles, allowing for intracellular and intranuclear localization and function. Indeed, a recently published study has shown that only apoE associated with lipids is capable of nuclear translocation [26] . These findings raise an interesting possibility that not only cytoplasmic, but also extracellular lipids can enter the nucleus, providing an important signaling mechanism through which astrocytes, for example, may be affecting neuronal nuclear-based functions associated with lipids. Our study provides evidence that at least a portion of secreted PLTP can re-enter the cell, and that PLTP can translocate to the nucleus upon re-entry. Interestingly, cells incubated with secreted PLTP-EGFP show variable intracellular fluorescence, suggesting the possibility that PLTP reuptake is regulated by some cellular parameter, such as the cell cycle stage.
It is also possible that the current cellular secretory pathway paradigm is not correct or that some sequence motif in a target protein may allow for exit from the secretory pathway and consequently permit intracellular or intranuclear localization. For example, numerous recent studies suggest involvement of the endoplasmic reticulum quality control system, ERAD, as a putative mechanism for transfer of proteins from the ER to cytoplasm and even nucleus [28] [29] [30] [31] [32] [33] . ERAD is typically involved in transfer of misfolded proteins from the ER for degradation by the ubiquitin system via an ER translocon, sec61. Recently published studies suggest that this system is also involved in transfer of secreted proteins to cytoplasmic and nuclear compartments [28] [29] [30] [31] [32] [33] . An interesting review by Arnoys and Wang lists nearly eighty well-documented secreted proteins that are localized in the nucleus [34] . Data from our experiments suggest that PLTP re-entry into the cell only partially explains PLTP presence in the nucleus, while additional nuclear PLTP likely comes from the intracellular pool that did not get secreted. Therefore, it would be important to further explore putative mechanisms involved in the intracellular and intranuclear localization of PLTP.
Although it is currently not known what functional roles PLTP may be playing in the nucleus, there are several likely possibilities.
Typically, shuttling of proteins between cytoplasm and nucleus is important for regulation of cellular functions, such as cell proliferation and differentiation, and for maintenance of the cellular structural stability and function. Alterations in nucleocytoplasmic shuttling for numerous transcription factors have been associated with pathophysiological processes involved in development of AD, Parkinson's disease, amyotrophic lateral sclerosis and Huntington's disease, among others (reviewed in [35] ). Gene expression can be regulated by factors that modify chromatin and by signaling molecules, as well as by factors regulating lipid content of the nucleus [35] [36] [37] .
We have shown that intranuclear PLTP is active in lipid transport, suggesting that PLTP may be involved in regulation, transport and distribution of phospholipids and cholesterol in the nucleus. Numerous studies have shown that lipids are an integral part of the nucleus [38] [39] [40] [41] [42] [43] . Lipids are present not only in the nuclear envelope, but also in the nuclear matrix and chromatin [37, [44] [45] . Additionally, elegant experiments by Albi et al. have shown that at least some of the phospholipids present in chromatin, which represent approximately 10% of the nuclear phospholipids, are transported into the nucleus from the cytoplasm [46] , while others may be synthesized in situ [37] . Although endonuclear lipids were initially considered relevant only for structural stability of the nucleus, an increasing body of evidence suggests their functional contribution to other nuclear processes. For example, endonuclear lipids have been associated with endonuclear lipid second messenger signaling, thus affecting processes involved in cell proliferation, differentiation and apoptosis [36, 37] . Furthermore, nuclear composition of lipids is cell type and cell cycle phase specific [37] . Despite the overwhelming evidence of lipid transfer of cholesterol and phospholipids to and from the nucleus, the processes and components of this lipid transfer are currently unknown [37] . Given the PLTP's wide affinity for free cholesterol and different classes of phospholipids, it is reasonable to speculate that PLTP may be involved in this process.
PLTP is also necessary for transfer of α-tocopherol to cells and tissues [11] . Guarnieri et al. have shown that α-tocopherol is present in the nuclei, and suggested that α-tocopherol may be involved in the regulation of RNA synthesis [47] . Further studies confirmed the importance of α-tocopherol in preservation of RNA structure, and reduction in nuclear α-tocopherol content had similar effects on nuclear components as aging [48] . Additionally, intranuclear antioxidative potential may be relevant not only in aging, but also in pathophysiology of various diseases, such as Alzheimer's disease or cancer. Since PLTP is critical for transfer of α-tocopherol to the cells, it is possible that it may be also involved in its transfer to the nucleus.
A recent study implicated PLTP as the main component in one of the nine pathways that regulate survival in breast cancer [49] , and PLTP has been differentially expressed in numerous tumors, including different types of leukemia ( [50] [51] [52] and data obtained through data mining), but the mechanisms through which PLTP may be affecting these processes are currently unknown. It is possible that intracellular, and in particular intranuclear PLTP localization and functions are relevant for these processes, and unraveling the mechanisms controlling PLTP intracellular compartmentalization would be important. Our study and its potential implications may be relevant for our understanding of the roles of PLTP in numerous human diseases, including Alzheimer's disease, cardiovascular disease, diabetes and cancer.
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